Grand Pharmaceutical’s new drup for treatment of brain tumors granted approval
Grand Pharmaceutical’s new drup for treatment of brain tumors granted approval

Grand Pharmaceutical’s new drup for treatment of brain tumors granted approval

 

>>REAL-TIME UPDATES IN THE WIRE. CLICK HERE<<<

 

 

A new drug for the treatment of brain tumors manufactured by Grand Pharmaceutical Group (HK: 0512) has been given the green light by Chinese regulators . . .

Sign In or Subscribe To Get Full Access. 

 

Join Us Now

 

We Are Live On THE WIRE Every Trading Day. Don't Miss Out. Grab Limited-Time Welcome Offer!

See Samples

 
 
 

Users' reviews 

 

They work with us

Sign Up For Free Weekly China Market Highlights HERE!Â